Mechanical circulatory support in acute cardiogenic shock.

F1000Prime Rep · 2014 · PMC4191250 · PMID 25374669

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In 1997, an analysis of patients in the Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Arteries (GUSTO-1) trial showed a trend toward lower 30-day and 1-year mortality in patients treated with an IABP and fibrinolytic therapy compared with fibrinolytic therapy alone [ 17 ].

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.